ORIGINAL RESEARCH
Published on 08 Nov 2021
Chimeric Antigen Receptor T Cells With Modified Interleukin-13 Preferentially Recognize IL13Rα2 and Suppress Malignant Glioma: A Preclinical Study
doi 10.3389/fimmu.2021.715000
- 6,144 views
- 17 citations
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- T Cell Therapy for CNS Tumors
T Cell Therapy for CNS Tumors
13k
Total downloads
42k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 07 Jun 2021
Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?
doi 10.3389/fimmu.2021.634031
- 2,914 views
- 3 citations
PERSPECTIVE
Published on 23 Mar 2021
Nanoparticles for Enhanced Adoptive T Cell Therapies and Future Perspectives for CNS Tumors
doi 10.3389/fimmu.2021.600659
- 9,726 views
- 30 citations
CASE REPORT
Published on 25 Feb 2021
Case Report: Reversible Neurotoxicity and a Clinical Response Induced by BCMA-Directed Chimeric Antigen Receptor T Cells Against Multiple Myeloma With Central Nervous System Involvement
doi 10.3389/fimmu.2021.552429
- 2,891 views
- 10 citations
REVIEW
Published on 12 Nov 2020
Strategies to Enhance the Efficacy of T-Cell Therapy for Central Nervous System Tumors
doi 10.3389/fimmu.2020.599253
- 3,778 views
- 11 citations
REVIEW
Published on 12 Aug 2020
CAR T Cell Therapy for Pediatric Brain Tumors
doi 10.3389/fonc.2020.01582
- 13,674 views
- 48 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 42kTopic views
- 28kArticle views
- 13kArticle downloads